IDEXX Laboratories, Inc. vs Royal Bank of Canada — how do they compare? IDEXX Laboratories, Inc. trades at $588.5 (market cap $46.22B), while Royal Bank of Canada trades at $210.44 (market cap $292.32B). The key difference: Royal Bank of Canada is far larger — about 6.3× IDEXX Laboratories, Inc.'s market cap, and Royal Bank of Canada pays a 2.37% dividend while IDEXX Laboratories, Inc. pays none. Which is the better fit depends on your goals.
| IDXX | RY | |
|---|---|---|
Market Cap | $46.22B | $292.32B |
Sector | Health | Financials |
52-Week High | $766.68 | $217.87 |
52-Week Low | $526.44 | $134.80 |
Enterprise Value | $47.12B | — |
Dividend Yield | — | 2.37% |
Trailing returns across standard periods
Latest headlines on both assets
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →Royal Bank of Canada is one of the two largest banks in Canada. It is a diversified financial services company, offering personal and commercial banking, wealth-management services, insurance, corporate banking, and capital markets services. The bank is concentrated in Canada, with additional operations in the U.S. and other countries.
Read more on RY →